AM-095

AM-095 Suppliers list
Company Name: BOC Sciences
Tel: +1-631-485-4226
Email: inquiry@bocsci.com
Products Intro: Product Name:AM095 sodium
CAS:1345614-59-6
Purity:>98% Package:1g Remarks:BOC Sciences also provides custom synthesis services for AM095 sodium.
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:AM095
CAS:1345614-59-6
Purity:99.62% Package:1 mg;1 mL * 10mM (in DMSO);10 mg;2 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel: 86-571-88216897,88216896 13588875226
Email: sales@hzclap.com
Products Intro: Product Name:AM095
CAS:1345614-59-6
Purity:126699% Package:10kg 25kg 200 kilograms per barrel Remarks:good
Company Name: Zhejiang J&C Biological Technology Co.,Limited
Tel: +1-2135480471 +1-2135480471
Email: sales@sarms4muscle.com
Products Intro: Product Name:AM095
CAS:1345614-59-6
Purity:99% Package:5KG;1KG Remarks:AM095
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:AM095 sodium
CAS:1345614-59-6
Purity:98% Package:5mg Remarks:V7134
AM-095 Basic information
Product Name:AM-095
Synonyms:AM-095;4'-[3-Methyl-4-[[[(1R)-1-phenylethoxy]carbonyl]amino]-5-isoxazolyl]-[1,1'-biphenyl]-4-acetic acid sodium salt (1:1);AM095 (Sodium Salt);AM095 >=98% (HPLC);AM095 sodium;sodium,2-[4-[4-[3-methyl-4-[[(1R)-1-phenylethoxy]carbonylamino]-1,2-oxazol-5-yl]phenyl]phenyl]acetate;(2-[4-[4-[3-methyl-4-[[(1R)-1-phenylethoxy]carbonylamino]-1,2-oxazol-5-yl]phenyl]phenyl]acetic acid) sodium salt;AM095 hydrochloride
CAS:1345614-59-6
MF:C27H25N2NaO5
MW:480.5
EINECS:
Product Categories:Inhibitors
Mol File:1345614-59-6.mol
AM-095 Structure
AM-095 Chemical Properties
storage temp. room temp
solubility ≥23.9 mg/mL in DMSO; insoluble in H2O; ≥16.77 mg/mL in EtOH with ultrasonic
form powder
color white to beige
Safety Information
MSDS Information
AM-095 Usage And Synthesis
Biological Activityam095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (lpa1) with ic50 values of 0.73 and 0.98 μm for mouse or recombinant human lpa1, respectively [1].
in vitroam095 has shown to inhibit lpa1-induced chemotaxis of both mouse lpa1/cho cells and human a2058 melanoma cells with ic50 values of 0.78 μm and 0.23μm [1].
in vivoam095 could dose-dependently block lpa-induced histamine release with an ed50 value of 8.3 mg/kg in mice. additionally, am095 has been revealed to remarkably reduce the balf collagen and protein with an ed50 value of 10 mg/kg in lungs. am095 has also shown to decrease both macrophage and lymphocyte infiltration induced by bleomycin in mice [1].
targetLPA1 receptor
references[1] swaney js1, chapman c, correa ld, stebbins kj, broadhead ar, bain g, santini am, darlington j, king cd, baccei cs, lee c, parr ta, roppe jr, seiders tj, ziff j, prasit p, hutchinson jh, evans jf, lorrain ds. pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. j pharmacol exp ther. 2011 mar;336(3):693-700.
AM-095 Preparation Products And Raw materials
Tag:AM-095(1345614-59-6) Related Product Information
Octadecyl methacrylate p-Tolualdehyde 2-Methylpropanedioic acid (S)-(+)-Benzyl glycidyl ether Benzyl alcohol 4'-Hydroxyacetophenone